SCHEMBL6895185

SCHEMBL6895185

Nc1ccc(Oc2ccnc3c2ccc2c(Oc4ccc(N)c(O)c4)ccnc23)cc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.40
PDGFRA P16234 2/20 0.38
PDGFRB P09619 1/20 0.38
HSP90AA1 P07900 2/20 0.38
HSP90AB1 P08238 2/20 0.38
IDO1 P14902 1/20 0.38
PSMB5 P28074 1/20 0.38
MMP14 P50281 2/20 0.38
AURKA O14965 3/20 0.36
MET P08581 3/20 0.36
TEK Q02763 3/20 0.36
AURKB Q96GD4 3/20 0.36
ABL1 P00519 1/20 0.36
LCK P06239 1/20 0.36
LYN P07948 1/20 0.36
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35
MMP2 P08253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894991 0.89 LOXL2 (0.43) KDRPDGFRAMMP14AURKAMET
SCHEMBL7062869 0.80 TTR (0.39) KDRPDGFRAMETGAARCE1
SCHEMBL29137432 0.78 PDGFRA (0.69) KDRPDGFRAPDGFRBAURKAMET
SCHEMBL4849002 0.76 GAA (0.47) IDO1MMP14NPC1MAPTTSHR
SCHEMBL17506817 0.75 CYP3A4 (0.43) MMP14MAPTRAB9AMMP2CYP3A4
SCHEMBL30040301 0.74 NR4A1 (0.61) HSP90AA1MMP14MAPTTSHRRAB9A
SCHEMBL436522 0.74 NR4A1 (0.61) HSP90AA1MMP14MAPTTSHRRAB9A
SCHEMBL17506790 0.74 CYP3A4 (0.42) MMP14MAPTTSHRRAB9AMMP2
SCHEMBL716943 0.73 GAA (0.52) MMP14NPC1MAPTTSHRRAB9A
SCHEMBL2178592 0.72 KDR (0.43) KDRPDGFRAPDGFRBAURKAMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6824949-B2 SELF-CONDENSATION OF AN O-AMINOPHENOLCARBOXYLIC ACID AND REACTION WITH BIS-O-AMINOPHENOLS ALONG WITH DICARBOXYLIC ACID AND ACETYLENE COMPOUNDS; HIGH RESISTANCE AGAINST THE DIFFUSION OF METALS INFINEON TECHNOLOGIES AG (DE) 2004-11-30 US disclosed
US-6531632-B2 Reacting dihydroxy compound with halogenated o-nitrophenol INFINEON TECHNOLOGIES AG (DE) 2003-03-11 US disclosed
US-20020086968-A1 Polybenzoxazole precursors, photoresist solution, polybenzoxazole, and process for preparing a polybenzoxazole precursor POLARIS INNOVATIONS LIMITED (IE) 2002-07-04 US disclosed
EP-1189974-A1 POLYBENZOXAZOLE PRECURSORS Infineon Technologies AG (DE) 2002-03-27 EP disclosed
US-20020010370-A1 Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same POLARIS INNOVATIONS LIMITED (IE) 2002-01-24 US disclosed
WO-2001066619-A1 POLYBENZOXAZOLE PRECURSORS INFINEON TECHNOLOGIES AG (DE) 2001-09-13 WO disclosed
EP-1132374-A2 Bis-o-aminophenols and o-aminophenolcarboxylic acids Infineon Technologies AG (DE) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010370-A1 Bis-o-aminophenols and o-aminophenolcarboxylic acids and process for preparing the same FOS, POF1B, FOSB KDR 4474/4885PDGFRA 4452/4885PDGFRB 4645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.